Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiviral potential of lactic acid bacteria and their bacteriocins.

Literature DB >> 24880436

Antiviral potential of lactic acid bacteria and their bacteriocins.

I Al Kassaa¹, D Hober, M Hamze, N E Chihib, D Drider.

Abstract

Emerging resistance to antiviral agents is a growing public health concern worldwide as it was reported for respiratory, sexually transmitted and enteric viruses. Therefore, there is a growing demand for new, unconventional antiviral agents which may serve as an alternative to the currently used drugs. Meanwhile, published literature continues shedding the light on the potency of lactic acid bacteria (LAB) and their bacteriocins as antiviral agents. Health-promoting LAB probiotics may exert their antiviral activity by (1) direct probiotic-virus interaction; (2) production of antiviral inhibitory metabolites; and/or (3) via stimulation of the immune system. The aim of this review was to highlight the antiviral activity of LAB and substances they produce with antiviral activity.

Entities: Chemical

Mesh：

Substances：

Year: 2014 PMID： 24880436 DOI： 10.1007/s12602-014-9162-6

Source DB: PubMed Journal: Probiotics Antimicrob Proteins ISSN： 1867-1306 Impact factor: 4.609

58 in total

1. Antiviral activity of enterocin CRL35 against herpesviruses.

Authors: M B Wachsman; M E Farías; E Takeda; F Sesma; A P de Ruiz Holgado; R A de Torres; C E Coto
Journal: Int J Antimicrob Agents Date: 1999-08 Impact factor: 5.283

Review 2. Probiotics as biotherapeutic agents: present knowledge and future prospects.

Authors: A Mercenier; S Pavan; B Pot
Journal: Curr Pharm Des Date: 2003 Impact factor: 3.116

Review 3. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials.

Authors: H Szajewska; J Z Mrukowicz
Journal: J Pediatr Gastroenterol Nutr Date: 2001-10 Impact factor: 2.839

Review 4. Human papilloma virus--role in precancerous and cancerous oral lesions of tobacco chewers.

Authors: Saeeda Baig; Ayesha Siddiqui; Amena Nayeem; Mohammad Salman; Moiz Ahmed Qidwai; Raiya Mallick; Samrah Qidwai
Journal: J Pak Med Assoc Date: 2013-10 Impact factor: 0.781

5. Evaluation of Leuconostoc mesenteroides YML003 as a probiotic against low-pathogenic avian influenza (H9N2) virus in chickens.

Authors: B J Seo; I A Rather; V J R Kumar; U H Choi; M R Moon; J H Lim; Y H Park
Journal: J Appl Microbiol Date: 2012-05-21 Impact factor: 3.772

6. Inhibition of human immunodeficiency virus type 1 by lactic acid bacteria from human breastmilk.

Authors: Virginia Martín; Antonio Maldonado; Leónides Fernández; Juan M Rodríguez; Ruth I Connor
Journal: Breastfeed Med Date: 2010-08 Impact factor: 1.817

7. Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions.

Authors: J A Hill; D J Anderson
Journal: Am J Obstet Gynecol Date: 1992-02 Impact factor: 8.661

8. Probiotic effects on cold and influenza-like symptom incidence and duration in children.

Authors: Gregory J Leyer; Shuguang Li; Mohamed E Mubasher; Cheryl Reifer; Arthur C Ouwehand
Journal: Pediatrics Date: 2009-07-27 Impact factor: 7.124

9. Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial.

Authors: E Guillemard; F Tondu; F Lacoin; J Schrezenmeir
Journal: Br J Nutr Date: 2009-09-14 Impact factor: 3.718

10. Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission.

Authors: S J Klebanoff; R W Coombs
Journal: J Exp Med Date: 1991-07-01 Impact factor: 14.307

39 in total

1. Bacteriocins: Not Only Antibacterial Agents.

Authors: Djamel Drider; Farida Bendali; Karim Naghmouchi; Michael L Chikindas
Journal: Probiotics Antimicrob Proteins Date: 2016-12 Impact factor: 4.609

2. In-silico design and molecular docking evaluation of peptides derivatives from bacteriocins and porcine beta defensin-2 as inhibitors of Hepatitis E virus capsid protein.

Authors: Carolina Quintero-Gil; Jaime Parra-Suescún; Albeiro Lopez-Herrera; Sergio Orduz
Journal: Virusdisease Date: 2017-06-09

Review 3. Nutraceuticals as modulators of gut microbiota: Role in therapy.

Authors: Eamonn M M Quigley
Journal: Br J Pharmacol Date: 2020-01-03 Impact factor: 8.739

Review 4. Recent advances in antiviral effects of probiotics: potential mechanism study in prevention and treatment of SARS-CoV-2.

Authors: Nima Montazeri-Najafabady; Kimia Kazemi; Ahmad Gholami
Journal: Biologia (Bratisl) Date: 2022-06-28 Impact factor: 1.653

5. Experimental elucidation of an antimycobacterial bacteriocin produced by ethnomedicinal plant-derived Bacillus subtilis (MK733983).

Authors: S Santhi Sudha; V Aranganathan
Journal: Arch Microbiol Date: 2021-02-05 Impact factor: 2.552

Review 6. Viral Infections, the Microbiome, and Probiotics.

Authors: Ashton Harper; Vineetha Vijayakumar; Arthur C Ouwehand; Jessica Ter Haar; David Obis; Jordi Espadaler; Sylvie Binda; Shrilakshmi Desiraju; Richard Day
Journal: Front Cell Infect Microbiol Date: 2021-02-12 Impact factor: 6.073

7. Probiotic Lactobacillus and Bifidobacterium strains possess safety characteristics, antiviral activities and host adherence factors revealed by genome mining.

Authors: Ahmed Ghamry Abdelhamid; Samar S El-Masry; Noha K El-Dougdoug
Journal: EPMA J Date: 2019-09-05 Impact factor: 6.543

8. Specific properties of probiotic strains: relevance and benefits for the host.

Authors: Rostyslav V Bubnov; Lidiia P Babenko; Liudmyla M Lazarenko; Victoria V Mokrozub; Mykola Ya Spivak
Journal: EPMA J Date: 2018-04-13 Impact factor: 6.543

Review 9. Exopolysaccharides as Antimicrobial Agents: Mechanism and Spectrum of Activity.

Authors: Abdelmoneim K Abdalla; Mutamed M Ayyash; Amin N Olaimat; Tareq M Osaili; Anas A Al-Nabulsi; Nagendra P Shah; Richard Holley
Journal: Front Microbiol Date: 2021-05-19 Impact factor: 5.640

10. Genome Features and In Vitro Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.

Authors: Irina V Soloveva; Tatyana N Ilyicheva; Vasiliy Yu Marchenko; Oleg V Pyankov; Anna G Tochilina; Irina V Belova; Vladimir A Zhirnov; Nikolay I Bormotov; Maksim O Skarnovich; Aleksander G Durymanov; Svetlana B Molodtsova; Ekaterina I Filippova; Alena S Ovchinnikova; Anastasia V Magerramova; Alexander B Ryzhikov; Rinat A Maksyutov
Journal: Biomed Res Int Date: 2021-06-18 Impact factor: 3.411